Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    03637491
Previous Study | Return to List | Next Study

A Study of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or Metastatic RAS-mutant Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03637491
Recruitment Status : Terminated (Available clinical data has shown limited anti-tumor activity and reaching target study drug dose levels may not be feasible.)
First Posted : August 20, 2018
Last Update Posted : July 23, 2021
Sponsor:
Information provided by (Responsible Party):
Pfizer

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 3, 2020
Actual Study Completion Date : February 2, 2021